TrialOncology2018

Yttrium-90-Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy after Cytoreduction with ESHAP Chemotherapy in Patients with Relapsed Follicular Non-Hodgkin Lymphoma: Final Results of a Phase II Study.

Soham D Puvvada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.